Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 17 Show results per page	View Search Criteria \| Help With Results


1.		Phase III Study of L-PAM vs P-32 and Persantine plus Aspirin vs Placebo for Thrombocytic Myeloproliferative Disorders

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				30 and over								PVSG-10

Last Modified: 4/26/2007


2.		Phase III Randomized Comparison of Recombinant IFN-A with vs without Aspirin in Patients with Advanced Renal Adenocarcinoma (Summary Last Modified 01/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				NCCTG-875001 MAYO-875001, NCCTG-87-50-01

Last Modified: 4/1/2000


3.		Phase III Randomized Chemoprevention Study of Aspirin in Patients with Curatively Treated Dukes' Stage A/B1/B2/C Colorectal Cancer (Summary Last Modified 04/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				over 30 to under 75				NCI				CLB-9270 E-C9270, NCCTG-949251, NCI-P93-0048, NCT00002527

Last Modified: 12/29/2008 First Published: 11/22/2004


4.		Phase III Randomized Study of Lenalidomide With Standard-Dose Versus Low-Dose Dexamethasone With or Without Salvage Therapy Comprising Thalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				ECOG-E4A03 E4A03, NCT00098475

Last Modified: 4/9/2007 First Published: 4/14/2006


5.		Phase III Randomized Study of Dexamethasone and Acetylsalicyclic Acid With Deferred Versus Immediate Diethylstilbestrol in Patients With Locally Advanced or Metastatic Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				Other				BARTS-DAVDAS EU-20610, ISRCTN13255144, NCT00316927

Last Modified: 12/1/1992


6.		Phase I/II Study of Chemoimmunotherapy with CTX/DOX/IFN-alfa plus IL-2/LAK Cells in Patients with Malignant Melanoma or Renal Cell Carcinoma (Summary Last Modified 12/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				BRMP-8802D NCI-88-C-84D, NCI-T88-0103N, T88-0103

Last Modified: 1/7/2008 First Published: 7/1/2000


7.		Phase II Study of Flavopiridol in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Completed				18 and over				NCI				NCI-00-C-0128 MB-401, NCI-T99-0066, T99-0066, NCT00020189

Last Modified: 4/26/2007


8.		Phase II Immunotherapy with IFL-rA plus Aspirin in Patients with Disseminated Malignant Melanoma and Advanced Renal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				MAYO-851901 NCI-T85-0264D, T85-0264

Last Modified: 9/1/1989


9.		Phase II Study of the Role of Nonsteroidal Anti-Inflammatory Agents in the Control of Pancreatic Cancer Pain (Summary Last Modified 09/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				no age specified								RPMI-DS-8816 NCI-V88-0553

Last Modified: 6/1/2005 First Published: 5/23/2003


10.		Phase II Randomized Study of Sulindac Versus Aspirin Versus Ursodiol for the Prevention of Colorectal Cancer in Patients With Aberrant Crypt Foci and a History of Colorectal Carcinoma or Adenoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				40 to 80				NCI				MDA-ID-01454 NCT00062023

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute